The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Lumen Technologies Inc
F:CYTH
|
US |
|
G
|
Gemfields Group Ltd
JSE:GML
|
GG |
|
F
|
Forestal Constructora y Comercial del Pacifico Sur SA
SGO:PASUR
|
CL |
|
S
|
Swiss Prime Site AG
SWB:SU1N
|
CH |
|
S
|
Saipem SpA
SWB:SPE
|
IT |
|
Insource Co Ltd
OTC:INSCF
|
JP |
|
G
|
Garmin Ltd
XMUN:GEY
|
CH |
|
A
|
Allstate Corp
SWB:ALS
|
US |
|
Pick N Pay Stores Ltd
F:PIK
|
ZA |
|
S
|
Snam SpA
XHAN:SNM
|
IT |
|
DMCI Holdings Inc
OTC:DMCIF
|
PH |
|
Block Inc
F:SQ3
|
US |
|
V
|
Valeo SE
SWB:VSA
|
FR |
|
Rocky Mountain Chocolate Factory Inc (Delaware)
F:RMFA
|
US |
|
R
|
Reservoir Media Inc
F:0RL0
|
US |
|
S
|
Stef SA
DUS:STP
|
FR |
|
Nifco Inc
OTC:NIFCF
|
JP |
|
S
|
Schindler Holding AG
SWB:SHR
|
CH |
|
Nephros Inc
NASDAQ:NEPH
|
US |
|
V
|
Vale SA
XMUN:CVLB
|
BR |
|
Keel Infrastructure Corp
F:9MK
|
US |
Lumen Technologies Inc (CYTH)’s 12-month stock price forecast through October 2027 has a consensus target of €11.39, implying 167% upside. The forecast is based on price targets from 11 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
CYTH is 11.39 EUR with a low forecast of 6.13 EUR and a high forecast of 14.34 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been -3%. The projected CAGR for the next 8 years is -3%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been -5%. The projected CAGR for the next 3 years is -8%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more